Citation 48354

POWELL,RG: WEISLEDER,D: SMITH JR,CR:. (1972). ANTITUMOR ALKALOIDS FROM CEPHALOTAXUS HARRINGTONIA: STRUCTURE AND ACTIVITY.. 61()

Citation Details

Title	ANTITUMOR ALKALOIDS FROM CEPHALOTAXUS HARRINGTONIA: STRUCTURE AND ACTIVITY.
Authors	POWELL,RG: WEISLEDER,D: SMITH JR,CR:
Year	1972
Volume	61
Issue

Summary

Year: 1972

Journal: Unknown

Organisms and Their Experiments (5)

Cephalotaxus harringtonia (CEPHALOTAXACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CEPHALOTAXINE	INACTIVE
2	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CEPHALOTAXINE	INACTIVE
3	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CEPHALOTAXINE	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE	ACTIVE
2	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE	ACTIVE
3	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE	ACTIVE
4	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE	ACTIVE
5	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE	ACTIVE
6	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,ISO:	ACTIVE
2	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,ISO:	ACTIVE
3	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,ISO:	ACTIVE
4	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,ISO:	INACTIVE
5	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,ISO:	INACTIVE
6	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,ISO:	INACTIVE
7	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,ISO:	ACTIVE
8	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,ISO:	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,HOMO:	ACTIVE
2	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,HOMO:	ACTIVE
3	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,HOMO:	ACTIVE
4	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,HOMO:	INACTIVE
5	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,HOMO:	INACTIVE
6	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,HOMO:	ACTIVE
7	ANTITUMOR ACTIVITY	STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,HOMO:	INACTIVE

Cephalotaxus harringtonia (CEPHALOTAXACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE

Show SPARQL Queries (1)